Ovarian Cancer: Can Repurposed Drugs Work Better Together?
A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability. Medscape News Global
Read the full article2d agoen
You might also wanna read
Public Wary of AI Scribes for Sensitive Consultations
Medscape·9h ago
MHRA Warns of Botulism Risk After Botulinum Toxin Use
Medscape·10h ago
Black, Asian Doctors Far Less Likely to Get Training Posts
Medscape·14h ago
JCVI Backs Routine MenB Vaccine for Teenagers
Medscape·16h ago
Lung Transplant for Lung Cancer: Promising, in Rare Cases
Medscape·18h ago
Updated Heart Failure Definition Loosens LVEF Cutoffs
Medscape·18h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.